Loomis, Sayles & Company’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.9M | Sell |
|
|||||
|
2025
Q1 | $47.2M | Sell |
|
|||||
|
2024
Q4 | $53M | Sell |
|
|||||
|
2024
Q3 | $47.3M | Sell |
|
|||||
|
2024
Q2 | $41.6M | Sell |
|
|||||
|
2024
Q1 | $54.5M | Sell |
|
|||||
|
2023
Q4 | $47.4M | Sell |
|
|||||
|
2023
Q3 | $47.7M | Buy |
|
|||||
|
2023
Q2 | $47.9M | Buy |
|
|||||
|
2023
Q1 | $56.5M | Buy |
|
|||||
|
2022
Q4 | $55.6M | Sell |
|
|||||
|
2022
Q3 | $54.2M | Sell |
|
|||||
|
2022
Q2 | $46.6M | Sell |
|
|||||
|
2022
Q1 | $52.7M | Sell |
|
|||||
|
2021
Q4 | $48.7M | Buy |
|
|||||
|
2021
Q3 | $44M | Buy |
|
|||||
|
2021
Q2 | $49.9M | Buy |
|
|||||
|
2021
Q1 | $11.3M | Buy |
|
|||||
|
2020
Q4 | $8.81M | Sell |
|
|||||
|
2020
Q3 | $7.54M | Sell |
|
|||||
|
2020
Q2 | $8.63M | Sell |
|
|||||
|
2020
Q1 | $6.76M | Sell |
|
|||||
|
2019
Q4 | $15M | Sell |
|
|||||
|
2019
Q3 | $30.7M | Buy |
|
|||||
|
2019
Q2 | $33.2M | Buy |
|
|||||
|
2019
Q1 | $14.9M | Sell |
|
|||||
|
2018
Q4 | $14.7M | Sell |
|
|||||
|
2018
Q3 | $28.9M | Sell |
|
|||||
|
2018
Q2 | $34.7M | Buy |
|
|||||
|
2018
Q1 | $26.3M | Sell |
|
|||||
|
2017
Q4 | $23.7M | Sell |
|
|||||
|
2017
Q3 | $25.9M | Sell |
|
|||||
|
2017
Q2 | $28.8M | Sell |
|
|||||
|
2017
Q1 | $21.6M | Sell |
|
|||||
|
2016
Q4 | $17.8M | Sell |
|
|||||
|
2016
Q3 | $18.4M | Sell |
|
|||||
|
2016
Q2 | $15.5M | Buy |
|
|||||
|
2016
Q1 | $12K | Buy |
|
|||||
|
2015
Q4 | $3K | Buy |
|